In patients with T2DM, glucagon levels are abnormally high during hyperglycemia, and lowering blood glucagon concentrations during hyperglycemia leads to reduced hepatic glucose output and reduced insulin requirements [41]. This evidence concerns the gene GCG and type 2 diabetes mellitus.